GRDN · XBRL financial data
Guardian Pharmacy Services financial statements, every quarter
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (GRDN's year ends in late December)
| In thousands of dollars | Sep 30, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 314,393 | 329,308 | 344,334 | 377,427 | 397,616* | 336,595 | 351,768 |
| Cost of goods and services sold | 253,515 | 264,959 | 276,188 | 302,706 | 312,114* | 260,286 | 271,724 |
| Gross profit | 60,878 | 64,349 | 68,146 | 74,721 | 85,502* | 76,309 | 80,044 |
| Selling, general and administrative | 165,491 | 51,344 | 55,566 | 58,367 | 54,740* | 58,634 | 59,400 |
| Operating income (loss) | (104,613) | 13,005 | 12,580 | 16,354 | 30,762* | 17,675 | 20,644 |
| Interest expense | 1,026 | 170 | 172 | 160 | 163* | 154 | 154 |
| Other income (expense) | (2) | 271 | 179 | 437 | 500* | 772 | 9,302 |
| Income tax expense (benefit) | 176 | 3,833 | 3,760 | 7,038 | 9,834* | 4,749 | 7,671 |
| Net income (loss) | (121,990) | 9,448 | 9,030 | 9,818 | 20,923* | 13,295 | 21,872 |
Balance sheet
CSVFiscal quarters (GRDN's year ends in late December)
Cash flows
CSVFiscal quarters (GRDN's year ends in late December)
| In thousands of dollars | Sep 30, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|
| Net income (loss) | (121,990) | 9,448 | 9,030 | 9,818 | 20,923* | 13,295 | 21,872 |
| Stock-based compensation | 122,356* | 3,968 | 4,447 | 4,356* | 1,080* | 1,861 | 2,932* |
| Depreciation and amortization | 4,994* | 5,267 | 5,489* | 5,838* | 5,741* | 5,976 | 5,808* |
| Net cash from operating activities | (2,164)* | 17,550 | 19,936* | 28,169* | 34,600* | 6,062 | 30,025* |
| Net cash from investing activities | (7,081)* | (5,545) | (13,004)* | (8,966)* | (4,710)* | (4,750) | (4,306)* |
| Proceeds from issuing common stock | — | 0 | 29,039* | 0* | 0* | 30,276 | 0* |
| Net cash from financing activities | 44,928* | (2,666) | (2,114)* | (1,533)* | (758)* | (2,038) | (805)* |
| Net change in cash | 35,683* | 9,339 | 4,818* | 17,670* | 29,132* | (726) | 24,914* |
Compare with peers
SIC 5912 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 5912 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (5912) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Guardian Pharmacy Services | 89,807 | 351,768 | 30,025* | not reported | — | 10-QJun 30, 2026 |
| Petmed Expressadded: same SIC | 13,079 | 41,015 | (7,687) | 21.7M | 1.7 quarters | 10-QJun 30, 2026 |
| CVS Healthadded: same SIC | 11,738,000 | 108,399,000 | 4,724,000* | 1.3B | — | 10-QSep 30, 2026 |
| AiXin Life Internationaladded: same SIC | 21 | 83* | (262)* | 25.0M | 0.1 quarters | 10-KDec 31, 2025 |
| TREES Corp (Colorado)added: same SIC | 245 | 3,310 | 99* | 108.7M | — | 10-QSep 30, 2024 |
| Flowerkist Skin Care & Cosmeticsadded: same SIC | not reported | not reported | not reported | not reported | — | — |
| Ridgetechadded: same SIC | 17,905 | year only | year only | 133.1M | — | 20-FMar 31, 2026 |
| 111added: same SIC | 510,967 | year only | year only | not reported | — | 20-FDec 31, 2025 |
Not investment advice. Not affiliated with the U.S. SEC.
